Allogeneic Hematopoietic Cell Transplantation in Patients Aged 50Years or Older with Severe Aplastic Anemia
Open Access
- 1 March 2019
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 25 (3) , 488-495
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Treatment of aplastic anaemia in elderly patients aged >60 yearsBone Marrow Transplantation, 2012
- Activity of alemtuzumab monotherapy in treatment-naive, relapsed, and refractory severe acquired aplastic anemiaBlood, 2012
- Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemiaBlood, 2011
- Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE projectBlood, 2010
- Outcome of Allogeneic Hematopoietic Cell Transplantation from HLA-Identical Siblings for Severe Aplastic Anemia in Patients Over 40 Years of AgeTransplantation and Cellular Therapy, 2010
- Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donorsHaematologica, 2010
- Diagnostic criteria to distinguish hypocellular acute myeloid leukemia from hypocellular myelodysplastic syndromes and aplastic anemia: recommendations for a standardized approachHaematologica, 2009
- Outcomes of older patients (≥60 years) with acquired aplastic anaemia treated with immunosuppressive therapyBritish Journal of Haematology, 2008
- Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemiaBlood, 2003
- Malignant Tumors Occurring after Treatment of Aplastic AnemiaNew England Journal of Medicine, 1993